RE: Roq interview9 Aug 2023 21:41
Exactly
He's been posting here for nearly 2 years. ROQ share price has been the same price since he first posted here but we have had huge progress here with the drug canditates, a 80% premium placing, countless directors buys in the hundreds of thousands of pounds, non stop postive news/updates and now in discussions with major pharmaceutical companies in regards to licensing deals or potential sales. This company has done everything they said they will do.
Whereas in the same timeframe his beloved EDL has dropped from 40p to 13p (6p at one stage), SYN has dropped from 0.30p to 0.11p. Both have made little to zero progress, many delays, countless discounted placings, share consolidations and zero director buys.
Obviously he's not a great investor and is pretty clueless when it comes to the stock market.